MAPT and Cognitive impairment: Genetic knockdown of CX3 CR1 in mice expressing human tau accelerated tau pathology that was driven by IL-1R and TLR-induced activation of p38 [337, 338], while upregulating CX3 CL1 expression ameliorated p-tau pathology and related cognitive deficits [339–341].